dengu
fever
viral
diseas
transmit
mosquito
genu
aed
princip
speci
aegypti
albopictu
infect
occur
mainli
tropic
subtrop
region
planet
number
case
past
year
increas
consider
diseas
affect
countri
around
world
million
case
year
thousand
requir
hospit
approxim
result
death
year
dengu
viru
denv
member
flavivirida
famili
envelop
viru
contain
kb
genom
posit
singlestrand
rna
encod
three
structur
protein
c
prm
e
seven
nonstructur
protein
four
serotyp
dengu
viru
caus
dengu
fever
df
sever
manifest
like
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
current
specif
antivir
compound
treatment
howev
sever
research
group
sought
antivir
compound
molecular
dock
use
medicin
plant
inhibit
viral
target
current
treatment
sever
dengu
support
fluid
therapi
medic
supervis
specif
antivir
therapi
antivir
agent
dengu
treatment
differ
method
prevent
establish
control
mosquito
reproduct
spread
due
lack
new
molecul
clinic
research
propos
repurpos
wellknown
drug
chloroquin
prednisolon
balapiravir
celgosivir
lovastatin
howev
although
drug
safe
success
decreas
viral
load
antigenemia
fever
induc
benefici
effect
dengu
patient
ethnopharmacolog
contribut
significantli
discoveri
new
drug
recent
year
focu
medicin
plant
wide
use
tradit
system
increas
worldwid
base
ethnobotan
inform
studi
demonstr
sever
compound
antidengu
potenti
activ
baicalein
catanospermin
quercetin
fisetin
within
mexican
popul
dengu
commonli
known
fiveday
fever
breakbon
fever
simpli
breaker
treatment
diseas
therapeut
resourc
tradit
medicin
whose
inform
collect
mani
year
import
databas
medicin
herbarium
mexican
social
secur
institut
herbarium
imssm
collect
multipl
use
medicin
plant
nativ
mexico
referenc
includ
tradit
use
dengu
taraxacum
officinal
urtica
dioica
calea
integrifolia
caesalpinia
pulcherrima
plant
wide
use
tradit
medicin
around
world
treatment
mani
ill
u
dioica
great
medicin
potenti
extract
use
treatment
eczema
digest
pain
anemia
arthriti
rheumat
inhibit
inflammatori
process
caus
season
allergi
officinal
use
treatment
anemia
liver
cirrhosi
rheumatoid
arthriti
also
report
antiinflammatori
antioxid
anticarcinogen
analges
antihyperglycem
lax
diuret
activ
also
stimul
digest
system
report
officinal
inhibitori
potenti
hiv
revers
transcriptas
c
pulcherrima
use
treatment
cough
contain
flavonoid
report
show
aqueou
extract
flower
leav
stem
inhibitori
effect
sever
virus
includ
herp
adenovirus
meanwhil
c
integrifolia
report
antihyperglycem
activ
use
treatment
diabet
plant
speci
udioica
report
sourc
antidengu
constitu
sinc
nacetyldglucosaminespecif
lectin
plant
uda
prove
effect
reduc
viral
infect
four
dengu
serotyp
howev
compound
distinct
protein
studi
therefor
work
analyz
aqueou
methanol
extract
four
plant
inhibitori
activ
replic
solvent
methanol
ethyl
acet
formic
acid
dimethyl
sulfoxid
dmso
reagent
hplc
grade
silica
gel
kiselgel
obtain
merck
kgaa
darmstadt
germani
media
supplement
cell
cultur
purchas
sigmaaldrich
chemic
st
loui
mo
usa
molecular
grade
agaros
obtain
promega
madison
usa
reagent
use
analyt
method
purchas
sigmaaldrich
chemic
except
otherwis
indic
cell
line
albopictu
maintain
minimum
essenti
medium
mem
supplement
fetal
bovin
serum
fb
uml
penicillin
streptomycin
cell
line
hamster
kidney
neonat
cultur
mem
supplement
fb
antibiot
cell
incub
recommend
type
experi
aed
albopictu
cell
atcc
use
viral
propag
babi
hamster
kidney
cell
atcc
use
quantifi
viru
plaqu
reduc
assay
dengu
viru
serotyp
strain
use
studi
kindli
provid
dr
alvaro
aguilarsetien
imss
mexico
citi
mexico
obtain
inoculum
use
experi
dengu
viru
replic
cell
day
subsequ
viral
supernat
centrifug
min
rpm
remov
cell
debri
aliquot
store
use
infect
cell
confirm
revers
transcriptionpolymeras
chain
reaction
rtpcr
use
report
specif
primer
immunofluoresc
use
antibodi
viral
prm
protein
previous
report
group
quantif
perform
lytic
plaqu
assay
cell
six
well
plate
h
cell
wash
pb
infect
serial
dilut
viru
inoculum
h
absorb
viru
remov
cell
wash
pb
agaros
dmem
ad
plate
incub
h
trichloroacet
acid
use
fix
cell
subsequ
stain
crystal
violet
ethanol
plant
speci
officinal
u
dioica
c
integrifolia
c
pulcherrima
use
studi
identifi
like
sourc
activ
compound
dengu
viru
ethnobotan
inform
obtain
herbarium
imssm
catalog
avail
paper
format
concern
use
syndrom
diseas
probabl
dengu
inflammatori
muscl
pain
plant
specimen
collect
state
puebla
mexico
municip
san
jeronimo
tecuanipan
north
west
atlixco
north
west
aerial
part
plant
crop
contaminantfre
cutter
transport
laboratori
veget
materi
taxonom
identifi
expert
herbarium
imssm
mexico
citi
refer
voucher
plant
materi
officinal
u
dioica
c
integrifolia
c
pulcherrima
deposit
code
imssm
respect
leav
plant
separ
wash
airdri
room
temperatur
week
grind
uniform
powder
blender
nutribullet
llc
pacoima
ca
usa
extract
pulver
plant
conduct
system
gerhardt
germani
use
methanol
water
solvent
extract
process
variabl
solvent
extract
temperatur
extract
time
min
reduct
rang
puls
reduct
remain
constant
methanol
aqueou
extract
dri
use
rotari
evapor
heidolph
instrument
gmbh
co
kg
germani
respect
dri
residu
weigh
dissolv
dmso
use
cytotox
inhibit
viral
replic
test
cytotox
concentr
obtain
cell
convent
mtt
bromid
colorimetr
assay
serial
dilut
extract
dmso
use
vehicl
extract
fraction
day
incub
cultur
medium
remov
cell
wash
twice
pb
standard
mtt
protocol
perform
experi
carri
triplic
done
twice
cell
seed
plate
h
infect
perform
ml
denv
inoculum
dilut
produc
approxim
lytic
plaqu
per
well
dilut
titrat
viral
inoculum
pfuml
h
incub
viral
inoculum
remov
wash
pb
twice
immedi
differ
concentr
extract
ad
control
inhibit
studi
use
cell
without
extract
without
infect
b
infect
cell
without
extract
c
cell
without
infect
extract
subsequ
molecular
biolog
grade
agaros
ad
final
concentr
dmem
fb
day
cell
fix
trichloroacet
acid
min
stain
crystal
violet
min
result
inhibit
viral
replic
report
percentag
form
lytic
plaqu
compar
control
infect
assay
treat
plant
extract
experi
carri
triplic
done
twice
officinal
u
dioica
extract
fraction
extract
suspend
deioniz
water
partit
twice
dichloromethan
solvent
exhaust
remov
obtain
dichloromethan
fraction
fraction
subject
silica
gel
column
cm
elut
gradient
nhexaneethyl
acet
yield
fraction
fraction
evalu
biolog
assay
chemic
analysi
mg
sampl
mix
ml
methanol
water
formic
acid
v
v
v
extract
vortex
sonic
ultrason
bath
min
room
temperatur
sampl
kept
overnight
sonic
min
centrifug
perform
min
rpm
separ
supernat
solid
residu
supernat
filter
pvdf
filter
analysi
millipor
usa
chromatograph
analys
identif
compound
carri
luna
column
mm
particl
size
phenomenex
macclesfield
uk
waterform
acid
vv
acetonitril
use
mobil
phase
b
respect
flow
rate
mlmin
linear
gradient
start
solvent
b
reach
solvent
b
min
min
min
maintain
min
inject
volum
analys
carri
use
agil
hplc
seri
model
equip
photodiod
array
detector
mass
detector
seri
agil
technolog
waldbronn
germani
equip
consist
binari
pump
model
autosampl
model
degass
model
photodiod
array
detector
model
hplc
system
control
chemstat
softwar
agil
version
mass
detector
ion
trap
spectromet
model
equip
electrospray
ioniz
interfac
control
lcmsd
softwar
agil
version
ioniz
condit
kv
capillari
temperatur
voltag
respect
nebul
pressur
nitrogen
flow
rate
psi
lmin
respect
fullscan
mass
cover
rang
mz
collisioninduc
fragment
experi
perform
ion
trap
use
helium
collis
ga
voltag
ramp
cycl
v
mass
spectrometri
data
acquir
posit
ioniz
mode
anthocyanin
neg
ioniz
mode
flavonoid
msn
carri
automat
mode
moreabund
fragment
ion
ms
calcul
cytotox
lytic
plaqu
reduct
graphpadpr
program
softwar
san
diego
ca
use
select
index
si
calcul
ratio
valu
extract
four
plant
speci
three
distinct
temperatur
use
two
solvent
obtain
extract
perform
triplic
therefor
final
individu
extract
evalu
cytotox
valu
rang
toxic
extract
c
pulcherrima
obtain
methanol
less
toxic
officinal
obtain
methanol
result
extract
shown
tabl
consid
cytotox
potenti
work
concentr
defin
evalu
antivir
activ
inhibitori
activ
infect
cell
cultur
differ
extract
test
aqueou
extract
show
littl
inhibit
potenti
exampl
c
pulcherrima
u
dioica
c
integrifolia
decreas
infect
level
aqueou
extract
higher
activ
denv
obtain
officinal
caus
inhibit
maximum
test
concentr
none
extract
decreas
number
lytic
plaqu
produc
viru
data
shown
none
aqueou
extract
use
subsequ
studi
methanol
extract
four
plant
inhibit
viral
replic
dosedepend
manner
howev
officinal
u
dioica
extract
reach
inhibit
lytic
plaqu
therefor
calcul
respect
si
valu
extract
tabl
fig
figur
show
exampl
inhibit
lytic
plaqu
methanol
extract
four
test
plant
extract
obtain
show
also
inhibit
properti
fig
valu
calcul
officinal
u
dioica
respect
tabl
fig
rest
extract
obtain
decreas
viral
infect
slightli
extract
obtain
four
plant
show
consist
inhibitori
effect
format
lytic
plaqu
fig
extract
officinal
u
dioica
obtain
methanol
fraction
seventeen
fraction
everi
extract
obtain
fraction
test
identifi
antivir
activ
quantifi
cytotox
higher
antivir
activ
identifi
fraction
f
officinal
u
dioica
respect
separ
assay
inhibit
replic
dosedepend
manner
calcul
valu
officinal
u
dioica
si
valu
respect
tabl
fig
analysi
officinal
show
major
peak
phenol
metabolit
previous
report
literatur
character
hplcpdaesimsm
neg
ioniz
mode
present
tabl
besid
compound
present
lesser
amount
compound
character
caffeoyl
hexosid
mz
show
loss
saccharid
moieti
da
caffeoylquin
acid
cqa
character
mean
deproton
molecular
ion
mz
give
base
peak
mz
mz
ion
weak
undetect
accord
clifford
et
al
label
acid
addit
caffeic
acid
dicaffeoylquin
acid
dicqa
mh
mz
also
present
besid
caffeoylquin
acid
two
dicaffeoyltartar
acid
deriv
detect
compon
show
mh
ion
mz
format
predomin
product
ion
mz
loss
caffeoyl
moieti
experi
loss
second
caffeic
acid
moieti
observ
result
base
peak
mz
sinc
fragment
alreadi
report
conclud
compound
chicor
acid
also
present
lettuc
respect
flavonoid
uv
chromatogram
hydroalcohol
extract
detect
seven
compound
compound
provid
mh
ion
mz
fragment
quercertin
diglycosid
pentos
hexos
moieti
link
distinct
posit
aglycon
mz
compound
show
uv
spectra
quercetin
deriv
deproton
molecular
ion
mz
fragment
gave
uniqu
peak
mz
correspond
deproton
ion
aglycon
well
absenc
intermedi
ion
indic
interglycosid
linkag
rhamnosyl
glucosid
rutinosid
data
indic
compound
rutin
wide
distribut
plant
also
present
sever
luteolin
glycosid
show
promin
fragment
mz
order
elut
ident
assign
accord
previou
report
presenc
compound
dandelion
accord
result
lcm
analys
major
fragment
esi
neg
mode
gallic
acid
syring
fumar
vanil
isorhamnetin
flavanol
sampl
chlorogen
acid
mz
rutin
mz
flavonol
glycosid
eg
quercetin
kaempferol
glycosid
mz
respect
tabl
multipl
studi
report
discoveri
obtain
compound
antidengu
properti
howev
commerci
avail
drug
treatment
dengu
present
studi
includ
plant
wide
use
tradit
medicin
mani
countri
treatment
mani
diseas
organ
disord
extract
select
plant
present
differ
activ
per
speci
temperatur
solvent
use
lesser
toxic
extract
officinal
obtain
methanol
toxic
methanol
extract
obtain
c
pulcherrima
perform
protocol
cell
infect
subsequ
plant
extract
ad
possibl
inhibitor
tri
simul
system
activ
denv
infect
like
occur
natur
infect
therefor
protocol
suggest
inhibitori
effect
viru
replic
obstruct
intermedi
step
replic
cycl
similar
report
experiment
inhibit
denv
possibl
interact
flavonoid
viral
enzym
involv
arn
synthesi
matur
polyprotein
compar
extract
obtain
three
differ
temperatur
observ
higher
inhibit
replic
obtain
fig
suggest
select
conserv
compound
antidengu
properti
time
temperatur
extract
compound
pharmacolog
potenti
import
paramet
optim
product
lower
cost
overal
process
differ
author
propos
increas
temperatur
extract
process
promot
increas
solubl
diffus
coeffici
phenol
compound
provid
caus
denatur
similar
process
occur
c
pulcherrima
aqueou
extract
plant
contain
compound
like
quercetin
broad
inhibitori
activ
adenoviru
herpesvirus
possibl
reason
activ
singl
molecul
mixtur
could
effect
differ
virus
differ
mechan
import
paramet
consid
select
index
si
rang
extract
fraction
valu
similar
report
natur
product
antidengu
activ
si
repres
rel
effect
product
inhibit
viral
replic
compar
induc
cell
citotox
high
therapeut
index
repres
rel
low
cytotox
high
antivir
activ
paramet
use
vitro
test
unlik
therapeut
index
measur
similar
mean
perform
vivo
work
aqueou
extract
show
less
inhibit
compar
extract
obtain
methanol
report
previous
assess
inhibitori
effect
aqueou
methanol
extract
hydrocotyl
sibthorpioid
replic
denv
hplcdpaesimsm
identifi
compound
officinal
u
dioica
fraction
quercetin
deriv
found
sever
studi
report
quercetin
antidengu
activ
although
specif
mechan
remain
undetermin
howev
interact
quercetin
deriv
proteas
envelop
e
protein
polymeras
predict
silico
method
hand
luteolin
deriv
found
officinal
fraction
luteolin
report
inhibitori
activ
sever
virus
enteroviru
coxsackieviru
chikungunya
viru
recent
articl
interact
one
identifi
compound
luteolin
deriv
predict
interact
proteas
use
silico
analysi
addit
recent
studi
show
luteolin
reduc
denv
infect
inhibit
human
furin
enzym
involv
matur
virion
wherebi
viral
particl
low
infecti
capac
produc
compound
identifi
officinal
caffeic
acid
caffeoylquin
acid
deriv
molecul
shown
inhibitor
import
virus
hepat
b
influenza
herp
simplex
recent
dengu
viru
last
studi
zanello
et
al
show
effect
two
deriv
four
denv
serotyp
interest
analyz
fraction
officinal
u
dioica
sever
molecul
demonstr
antivir
activ
recent
antiretrovir
activ
aqueou
extract
officinal
identifi
studi
identifi
inhibitori
effect
yellow
fever
viru
prototyp
flavivirida
possibl
differ
compound
plant
could
effect
differ
virus
studi
recogn
compon
present
faction
determin
identifi
probabl
antidengu
molecul
andor
effect
virus
includ
recent
mosquitoborn
emerg
virus
chikungunya
zika
also
necessari
studi
formul
sever
activ
compound
fraction
search
probabl
synerg
process
inhibit
viru
infect
group
current
perform
studi
